Showing results 8 to 15 of 15
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
2016 | |||
Repeat dosing of the GalNAc-siRNA AB-729 in subjects with chronic hepatitis B results in robust and sustained HBsAg suppression Proceeding/Conference:Journal of Hepatology | 2021 | ||
Restoration of HBV-specific immune responses with therapeutic vaccine BRII-179 (VBI-2601) in chronic HBV patients in a phase 1b/ 2a study Proceeding/Conference:Journal of Hepatology | 2021 | ||
2016 | |||
4-Oct-2022 | |||
2019 | |||
The pharmacokinetic and safety profiles of RO7445482 SIRNA are similar between Asian and nonAsian healthy volunteers and chronic hepatitis B patients in a phase 1 Study Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
2021 |